You are here

Nicole van Grieken, MD, PhD

Department of Pathology, VU University Medical Center, Amsterdam, Netherlands

Nicole van Grieken is a surgical pathologist specializing in gastrointestinal (GI) pathology, hereditary tumours, and hepatobiliary pathology. Dr van Grieken gained her PhD on morphological and chromosomal alterations in gastric carcinogenesis in 2003, and her MD in 2004; she commenced training in surgical pathology in Amsterdam and Haarlem, the Netherlands, in 2004. She is now a staff member in the Department of Pathology at the VU University Medical Center (VUmc) in Amsterdam, a post she has held since 2009.

Dr van Grieken has a special interest in translational research on GI oncology, particularly gastro-oesophageal cancer. Her main scientific interest is in the identification of molecular alterations that can serve as prognostic and predictive biomarkers, with the aim of developing personalized therapies adapted to individual patient or tumour characteristics. She is responsible for the central pathology review and translational research programme of several clinical trials on gastric and colorectal cancer. She is committed to improving the quality of patient care by participating in guideline development for gastric and oesophageal cancer.

Dr van Grieken is secretary and board member of the Dutch Upper GI Cancer Group (DUCG) and a member of the scientific committee of the Dutch Upper GI Cancer Audit (DUCA). She has published many peer-reviewed articles in journals including The Lancet, Lancet Oncology, Journal of Clinical Oncology, Gastroenterology, Journal of Medical Genetics, Oncogenesis, Journal of Pathology, and British Journal of Cancer.


Search this site

Search form

ECCO2017 symposium webcast: Treatment evolution in advanced GI malignancies

Welcome and introduction - Florian Lordick

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Featured Content

New Book Content


This online Resource Centre has been sponsored by Lilly Oncology

Note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subject to an independent editorial review.

Share